|
|
|
|||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
| (Continued from page 14) | |||||||||||||||||||||||||||||||||||||
|
6. Quinlivan EP, McPartlin J, McNulty H, Ward M, et al. Importance Of Both Folic Acid And Vitamin B12 In Reduction Of Risk Of Vascular Disease. Lancet 2002;359(9302):227-8. 7. Schnyder G, Roffi M, Flammer Y, Pin R, et al. Effect Of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, And Vitamin B6 On Clinical Outcome After Percutaneous Coronary Intervention The Swiss Heart Study: A Randomized Controlled Trial. JAMA 2002;288(8):973-979. 8. Schnyder G, Roffi M, Pin R, Flammer Y, et al. Decreased Rate Of Coronary Restenosis After Lowering Of Plasma Homocysteine Levels. N Engl J Med 2001;345(22):1593-600. 9. Nallamothu BK, Fendrick
AM, Rubenfire M, Saint S, et al. Potential Clinical and Economic Effects
of Homocyst(e)ine Lowering. Arch
Intern Med 2000;160:3406-3412.
|
||||||||||||||||||||||||||||||||||||
|
|
|
|
|
PO Box 39385 Fort Lauderdale, FL 33339-9385 USA |
|
Any use of the information presented herein is done strictly at your own risk. No responsibility is implied or intended on the part of HIV ReSources Inc, the editor, or the publisher. Information on this site should not be construed as an endorsement of any kind. |
|
|